Published in Cancer Epidemiol Biomarkers Prev on October 25, 2011
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev (2014) 1.73
Chronic tamoxifen use is associated with a decreased risk of intestinal metaplasia in human gastric epithelium. Dig Dis Sci (2013) 1.43
Clinicopathological characteristics and prognosis of signet ring cell carcinoma of the stomach. Gastric Cancer (2013) 1.04
Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies. PLoS One (2013) 0.96
MicroRNA: A Bridge from H. pylori Infection to Gastritis and Gastric Cancer Development. Front Genet (2012) 0.91
Why does Jack, and not Jill, break his crown? Sex disparity in brain tumors. Biol Sex Differ (2012) 0.90
Coffee intake and gastric cancer risk: the Singapore Chinese health study. Cancer Epidemiol Biomarkers Prev (2014) 0.87
Prognostic role of lemur tyrosine kinase-3 germline polymorphisms in adjuvant gastric cancer in Japan and the United States. Mol Cancer Ther (2013) 0.85
Age and sex interactions in gastric cancer incidence and mortality trends in Korea. Gastric Cancer (2014) 0.85
Intake of soy products and other foods and gastric cancer risk: a prospective study. J Epidemiol (2013) 0.84
Helminth co-infection in Helicobacter pylori infected INS-GAS mice attenuates gastric premalignant lesions of epithelial dysplasia and glandular atrophy and preserves colonization resistance of the stomach to lower bowel microbiota. Microbes Infect (2014) 0.84
Reproductive factors and risk of esophageal squamous cell carcinoma in northern Iran: a case-control study in a high-risk area and literature review. Eur J Cancer Prev (2013) 0.83
Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973-2008). Dis Esophagus (2013) 0.83
Sex differences in cancer survival in Estonia: a population-based study. BMC Cancer (2015) 0.83
Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection. Gastric Cancer (2014) 0.83
One-carbon metabolism dietary factors and distal gastric cancer risk in chinese women. Cancer Epidemiol Biomarkers Prev (2014) 0.81
Serum TFF3 may be a pharamcodynamic marker of responses to chemotherapy in gastrointestinal cancers. BMC Clin Pathol (2014) 0.81
Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients. Pharmacogenet Genomics (2014) 0.80
Parity and gastric cancer risk: a systematic review and dose-response meta-analysis of prospective cohort studies. Sci Rep (2016) 0.79
Sex disparities in the association of lung adenocarcinoma with colorectal cancer. J Cancer (2013) 0.78
Risk of pneumonia in central nervous system injury with alcohol intake: a meta-analysis. Int J Clin Exp Med (2015) 0.77
17β-estradiol inhibits mesenchymal stem cells-induced human AGS gastric cancer cell mobility via suppression of CCL5- Src/Cas/Paxillin signaling pathway. Int J Med Sci (2013) 0.77
Prognostic role of lemur tyrosine kinase 3 in postoperative gastric cancer. Mol Clin Oncol (2014) 0.76
Suppression of IL-8-Src signalling axis by 17β-estradiol inhibits human mesenchymal stem cells-mediated gastric cancer invasion. J Cell Mol Med (2016) 0.76
Genetic susceptibility factors on genes involved in the steroid hormone biosynthesis pathway and progesterone receptor for gastric cancer risk. PLoS One (2012) 0.76
mRNA expression of steroidogenic enzymes, steroid hormone receptors and their coregulators in gastric cancer. Oncol Lett (2017) 0.75
Reproductive factors, hormones and colorectal cancer-still unresolved. Br J Cancer (2016) 0.75
Impact of age on clinicopathological features and survival of patients with noncardia gastric adenocarcinoma. J Gastric Cancer (2014) 0.75
MDM4 genetic variants and risk of gastric cancer in an eastern chinese population. Oncotarget (2017) 0.75
A Point Mutation in DNA Polymerase β (POLB) Gene Is Associated with Increased Progesterone Receptor (PR) Expression and Intraperitoneal Metastasis in Gastric Cancer. J Cancer (2016) 0.75
Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer. Pharmacogenomics J (2015) 0.75
Causal Therapy of Breast Cancer Irrelevant of Age, Tumor Stage and ER-Status: Stimulation of Estrogen Signaling Coupled With Breast Conserving Surgery. Recent Pat Anticancer Drug Discov (2016) 0.75
Clinicopathological features and trend changes of gastric carcinoma in Southern China. World J Gastroenterol (2014) 0.75
Flavan-3-ols consumption and cancer risk: A meta-analysis of epidemiologic studies. Oncotarget (2016) 0.75
A nomogram to predict lymph node metastasis in patients with early gastric cancer. Oncotarget (2017) 0.75
A MAP3k1 SNP predicts survival of gastric cancer in a Chinese population. PLoS One (2014) 0.75
Review of tumor dormancy therapy using traditional oriental herbal medicine. J Pharmacopuncture (2013) 0.75
Status of Epstein-Barr Virus Coinfection with Helicobacter pylori in Gastric Cancer. J Oncol (2017) 0.75
Age trend of the male to female sex ratio in surgical gastric cancer patients at a single institution. World J Surg Oncol (2014) 0.75
Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Gastroenterol Clin North Am (2015) 0.75
Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain. PLoS One (2016) 0.75
Genetically predicted high body mass index was associated with increased gastric cancer risk. Eur J Hum Genet (2017) 0.75
Screening and Preventive Strategies in Esophagogastric Cancer. Surg Oncol Clin N Am (2017) 0.75
Gastrointestinal Complications of Obesity. Gastroenterology (2017) 0.75
Meta-analysis in clinical trials. Control Clin Trials (1986) 144.91
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer (2010) 90.16
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97
Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum (2004) 14.27
Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst (2005) 7.70
Epidemiology of gastric cancer. World J Gastroenterol (2006) 7.67
Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst (1994) 6.37
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med (2004) 5.67
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors. J Natl Cancer Inst (1996) 5.28
Tamoxifen in the treatment of breast cancer. N Engl J Med (1998) 4.75
A model for gastric cancer epidemiology. Lancet (1975) 4.02
Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group. J Natl Cancer Inst (1995) 3.79
Second cancers after adjuvant tamoxifen therapy for breast cancer. J Natl Cancer Inst (1996) 3.26
Trefoil factors: initiators of mucosal healing. Nat Rev Mol Cell Biol (2003) 2.86
Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clin Proc (2006) 2.83
Cholesterol glucosylation promotes immune evasion by Helicobacter pylori. Nat Med (2006) 2.53
Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology (2009) 2.39
A study of cancer, parity and age at first pregnancy. J Chronic Dis (1980) 2.13
Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy. J Natl Cancer Inst (2007) 1.97
Menstrual and reproductive risk factors and risk for gastric adenocarcinoma in women: findings from the canadian national enhanced cancer surveillance system. Ann Epidemiol (2006) 1.88
Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control (2005) 1.80
Tamoxifen for early breast cancer. Cochrane Database Syst Rev (2001) 1.75
Height, weight, menstrual and reproductive factors and risk of gastric cancer among Japanese postmenopausal women: analysis by subsite and histologic subtype. Int J Cancer (2002) 1.74
Helicobacter pylori infection in the Colombian Andes: a population-based study of transmission pathways. Am J Epidemiol (1996) 1.69
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study. J Clin Oncol (1994) 1.67
Meta-analysis, Simpson's paradox, and the number needed to treat. BMC Med Res Methodol (2002) 1.66
Smoking increases the treatment failure for Helicobacter pylori eradication. Am J Med (2006) 1.62
The epidemiology of Helicobacter pylori in Peruvian children between 6 and 30 months of age. Am J Gastroenterol (1994) 1.62
Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death. J Clin Oncol (1993) 1.55
Sex differences in fruit and vegetable intake in older adults. Appetite (2003) 1.52
Meta-analysis of vascular and neoplastic events associated with tamoxifen. J Gen Intern Med (2003) 1.51
Oestrogen and the enigmatic male predominance of gastric cancer. Eur J Cancer (2008) 1.48
Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer (2002) 1.48
Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies. Int J Cancer (2003) 1.46
Long-term impact of reproductive factors on cancer risk. Int J Cancer (1993) 1.45
Risk of second cancer among women with breast cancer. Int J Cancer (2006) 1.41
Second cancers after conservative surgery and radiation for stages I-II breast cancer: identifying a subset of women at increased risk. Int J Radiat Oncol Biol Phys (2001) 1.40
Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. Am J Epidemiol (1995) 1.24
Estrogen receptor beta is expressed in human stomach adenocarcinoma. J Cancer Res Clin Oncol (2002) 1.23
Estrogen and risk of gastric cancer: a protective effect in a nationwide cohort study of patients with prostate cancer in Sweden. Cancer Epidemiol Biomarkers Prev (2004) 1.22
Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden. Br J Cancer (2006) 1.22
Oral contraceptives and breast cancer. Review and meta-analysis. Cancer (1990) 1.21
Parity in relation to mortality and cancer incidence: a prospective study of Norwegian women. Int J Epidemiol (1994) 1.21
Fruit and vegetable consumption and gastric cancer by location and histological type: case-control and meta-analysis. Eur J Cancer Prev (2007) 1.21
Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea. World J Gastroenterol (2010) 1.19
Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst (1991) 1.18
Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis. Br J Cancer (2011) 1.18
Menstrual and reproductive factors and gastric cancer risk in a large prospective study of women. Gut (2007) 1.17
Menstrual and reproductive factors and gastric-cancer risk in women. Int J Cancer (1994) 1.17
Reproductive history and gastric cancer among post-menopausal women. Int J Cancer (1994) 1.16
Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas. Br J Cancer (2006) 1.16
Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Ann Oncol (2000) 1.13
Helicobacter pylori infection in Finnish children and adolescents. A serologic cross-sectional and follow-up study. Scand J Gastroenterol (1995) 1.11
Helicobacter pylori infection and gender: a meta-analysis of population-based prevalence surveys. Dig Dis Sci (2006) 1.09
Menstrual and reproductive factors and risk of gastric cancer: a Norwegian cohort study. Cancer Causes Control (2000) 1.09
Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Cancer Cohort. Cancer Epidemiol Biomarkers Prev (2010) 1.07
Parity and cancer risk in Slovakia. Int J Cancer (1985) 1.07
Menopausal hormone therapy and risk of gastrointestinal cancer: nested case-control study within a prospective cohort, and meta-analysis. Int J Cancer (2011) 1.06
The association of menstrual and reproductive factors with upper gastrointestinal tract cancers in the NIH-AARP cohort. Cancer (2010) 1.05
Protective role of 17 beta -estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice. Carcinogenesis (2007) 1.04
Menstrual and reproductive factors and the mortality risk of gastric cancer in Japanese menopausal females. Cancer Causes Control (2003) 1.04
Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection. Proc Natl Acad Sci U S A (2009) 1.04
Effect of sex hormones on the experimental induction of cancer in rat stomach - a preliminary study. Digestion (1982) 1.02
Seroconversion and seroreversion in IgG antibodies to Helicobacter pylori: a serology based prospective cohort study. J Epidemiol Community Health (2000) 1.02
17β-estradiol and tamoxifen prevent gastric cancer by modulating leukocyte recruitment and oncogenic pathways in Helicobacter pylori-infected INS-GAS male mice. Cancer Prev Res (Phila) (2011) 1.01
The sex ratio in gastric cancer and hypothetical considerations relative to aetiology. Br J Cancer (1968) 1.00
Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. Int J Cancer (2009) 1.00
Smoking and Helicobacter pylori infection in a sample of U.S. adults. Epidemiology (2005) 0.98
Tamoxifen and risk of large bowel cancer in women with breast cancer. Breast Cancer Res Treat (1999) 0.98
Female reproductive factors and the risk of gastric cancer in a large-scale population-based cohort study in Japan (JPHC study). Eur J Cancer Prev (2008) 0.94
Aberrant methylation of multiple genes in gastric carcinomas. Int J Surg Pathol (2007) 0.92
Menstrual and reproductive factors, exogenous hormone use, and gastric cancer risk in a cohort of women from the European Prospective Investigation Into Cancer and Nutrition. Am J Epidemiol (2010) 0.92
Steroid hormones as bactericidal agents to Helicobacter pylori. FEMS Microbiol Lett (2011) 0.91
Parity and risk of stomach cancer by sub-site: a national Swedish study. Br J Cancer (2008) 0.90
The Christie hospital adjuvant tamoxifen trial--status at 10 years. Br J Cancer (1988) 0.89
Fruit and vegetable intake in Austrian adults: intake frequency, serving sizes, reasons for and barriers to consumption, and potential for increasing consumption. Public Health Nutr (2009) 0.88
Disparities in hormone replacement therapy use by socioeconomic status in a primary care population. J Community Health (2001) 0.86
Polymorphisms in estrogen- and androgen-metabolizing genes and the risk of gastric cancer. Carcinogenesis (2008) 0.85
Reproductive history and health screening for women and mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC). Asian Pac J Cancer Prev (2007) 0.84
Long-term effects of adjuvant tamoxifen and/or radiotherapy. The South Sweden Breast Cancer Trial. Acta Oncol (1992) 0.84
Male predominance of upper gastrointestinal adenocarcinoma cannot be explained by differences in tobacco smoking in men versus women. Eur J Cancer (2010) 0.84
Steroids mediate resistance to the bactericidal effect of phosphatidylcholines against Helicobacter pylori. FEMS Microbiol Lett (2009) 0.83
Hormone receptors in gastric cancer. Eur J Cancer Clin Oncol (1983) 0.82
Adjuvant tamoxifen in early-stage breast cancer: effects on intercurrent morbidity and mortality. J Clin Oncol (1991) 0.82
Effects of 17beta-estradiol administration on apoptosis and polyamine content in AGS cell line. Anticancer Res (2002) 0.81
17 β-estradiol suppresses Helicobacter pylori-induced gastric pathology in male hypergastrinemic INS-GAS mice. Carcinogenesis (2011) 0.81
Anabolic utilization of steroid hormones in Helicobacter pylori. FEMS Microbiol Lett (2009) 0.80
Does breastfeeding affect the risk of gastric cancer? Int J Cancer (2003) 0.80
Persisting Helicobacter antibodies in Finnish children and adolescents between two and twenty years of age. Pediatr Infect Dis J (1998) 0.80
The Christie Hospital adjuvant tamoxifen trial. J Natl Cancer Inst Monogr (1992) 0.79
Higher parity associated with higher risk of death from gastric cancer. World J Gastroenterol (2011) 0.79
Seroconversion and seroreversion of Helicobacter pylori antibodies over a 9-year period and related factors in Japanese adults. Helicobacter (2004) 0.79
The effect of nitric oxide, growth factors, and estrogen on gastric cell migration. J Surg Res (2007) 0.77
Helicobacter pylori serology in a birth cohort of New Zealanders from age 11 to 26. World J Gastroenterol (2005) 0.77
Endometrial and other primary cancers after tamoxifen treatment of breast cancer -- results of retrospective cohort study. Eur J Obstet Gynecol Reprod Biol (2001) 0.76
Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion. Cancer Res (2005) 6.66
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet (2011) 5.21
Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses. Cancer Res (2004) 4.74
Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res (2009) 4.16
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma. J Exp Med (2005) 3.80
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology (2003) 3.58
Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science (2004) 3.06
The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol (2006) 2.93
L-arginine consumption by macrophages modulates the expression of CD3 zeta chain in T lymphocytes. J Immunol (2003) 2.91
Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA (2010) 2.78
Regulation of T cell receptor CD3zeta chain expression by L-arginine. J Biol Chem (2002) 2.62
Cancer survivorship--genetic susceptibility and second primary cancers: research strategies and recommendations. J Natl Cancer Inst (2006) 2.42
Agile patency system eliminates risk of capsule retention in patients with known intestinal strictures who undergo capsule endoscopy. Gastrointest Endosc (2008) 2.42
Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location. Gastroenterology (2009) 2.39
Helicobacter pylori genome evolution during human infection. Proc Natl Acad Sci U S A (2011) 2.15
Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. Cancer Res (2008) 2.08
Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk. Gut (2011) 2.08
Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via L-arginine metabolism. Cancer Res (2009) 1.99
A functional polymorphism of toll-like receptor 4 gene increases risk of gastric carcinoma and its precursors. Gastroenterology (2006) 1.98
Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev (2008) 1.96
Endoscopic retrograde cholangiopancreatography with single-balloon enteroscopy is feasible in patients with a prior Roux-en-Y anastomosis. Dig Dis Sci (2008) 1.93
Interleukin-1B polymorphisms and gastric cancer risk--a meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 1.90
Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms and gastric cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev (2006) 1.69
Enhanced humoral and Type 1 cellular immune responses with Fluzone adjuvanted with a synthetic TLR4 agonist formulated in an emulsion. Vaccine (2009) 1.60
Virulence-associated genotypes of Helicobacter pylori: do they explain the African enigma? Am J Gastroenterol (2002) 1.60
Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol (2007) 1.54
Markers of microbial translocation and risk of AIDS-related lymphoma. AIDS (2013) 1.53
Decreased expression of CD3zeta and nuclear transcription factor kappa B in patients with pulmonary tuberculosis: potential mechanisms and reversibility with treatment. J Infect Dis (2006) 1.53
Improved survival of gastric cancer with tumour Epstein-Barr virus positivity: an international pooled analysis. Gut (2013) 1.49
Delayed rise in incidence of gastric cancer in females results in unique sex ratio (M/F) pattern: etiologic hypothesis. Gastric Cancer (2002) 1.48
Human and Helicobacter pylori coevolution shapes the risk of gastric disease. Proc Natl Acad Sci U S A (2014) 1.48
L-Arginine modulates CD3zeta expression and T cell function in activated human T lymphocytes. Cell Immunol (2005) 1.45
Iron deficiency accelerates Helicobacter pylori-induced carcinogenesis in rodents and humans. J Clin Invest (2012) 1.45
Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells. Gastroenterology (2010) 1.45
Studies of trypanosomiasis in the Luangwa valley, north-eastern Zambia. Parasit Vectors (2015) 1.43
Intestinal helminthiasis in Colombian children promotes a Th2 response to Helicobacter pylori: possible implications for gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev (2005) 1.43
B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma. Cancer Epidemiol Biomarkers Prev (2011) 1.41
Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA. Gastroenterology (2011) 1.41
Lymphoma- and leukemia-associated chromosomal translocations in healthy individuals. Genes Chromosomes Cancer (2003) 1.41
A multicenter, U.S. experience of single-balloon, double-balloon, and rotational overtube-assisted enteroscopy ERCP in patients with surgically altered pancreaticobiliary anatomy (with video). Gastrointest Endosc (2013) 1.39
Optimized subunit vaccine protects against experimental leishmaniasis. Vaccine (2009) 1.39
Helicobacter pylori arginase inhibits T cell proliferation and reduces the expression of the TCR zeta-chain (CD3zeta). J Immunol (2004) 1.37
Epidemiology of AIDS-related malignancies an international perspective. Hematol Oncol Clin North Am (2003) 1.37
Circulating serum free light chains as predictive markers of AIDS-related lymphoma. J Clin Oncol (2010) 1.36
Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells. Infect Immun (2007) 1.34
Interaction of Helicobacter pylori with gastric epithelial cells is mediated by the p53 protein family. Gastroenterology (2008) 1.33
Frequent overexpression of Aurora Kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions. Cancer (2008) 1.32
Inverse association of esophageal eosinophilia with Helicobacter pylori based on analysis of a US pathology database. Gastroenterology (2011) 1.29
Eosinophils and mast cells in chronic gastritis: possible implications in carcinogenesis. Hum Pathol (2008) 1.27
Race, African ancestry, and Helicobacter pylori infection in a low-income United States population. Cancer Epidemiol Biomarkers Prev (2011) 1.26
Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda. AIDS (2009) 1.21
Genetic factors involved in the development of Helicobacter pylori-related gastric cancer. Cancer Sci (2006) 1.21
Sexually transmissible infections and prostate cancer risk. Cancer Epidemiol Biomarkers Prev (2008) 1.21
Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: subsite and histology differences. Cancer Causes Control (2007) 1.20
Genomic changes during chronic Helicobacter pylori infection. J Bacteriol (2006) 1.20
Age at acquisition of Helicobacter pylori infection: comparison of two areas with contrasting risk of gastric cancer. Helicobacter (2004) 1.18
Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer. Int J Cancer (2010) 1.18
Single-balloon enteroscopy: results from an initial experience at a U.S. tertiary-care center. Gastrointest Endosc (2010) 1.18
Genetic variation in the prostate stem cell antigen gene and upper gastrointestinal cancer in white individuals. Gastroenterology (2010) 1.18
Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood (2010) 1.17
Gastric cancer: an infectious disease. Infect Dis Clin North Am (2010) 1.17
Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations. Eur J Cancer Prev (2012) 1.17
Purification and characterization of Helicobacter pylori arginase, RocF: unique features among the arginase superfamily. Eur J Biochem (2004) 1.16
Ethnic differences in cytokine gene polymorphisms: potential implications for cancer development. Cancer Immunol Immunother (2007) 1.15
Epidemiology of Helicobacter pylori infection in six Latin American countries (SWOG Trial S0701). Cancer Causes Control (2012) 1.15
Loss of TFF1 is associated with activation of NF-κB-mediated inflammation and gastric neoplasia in mice and humans. J Clin Invest (2011) 1.15
Impact of Helicobacter pylori infection on growth of children: a prospective cohort study. J Pediatr Gastroenterol Nutr (2003) 1.14
Risk factors for Kaposi's sarcoma among HHV-8 seropositive homosexual men with AIDS. Int J Cancer (2005) 1.14
Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men. Cancer Epidemiol Biomarkers Prev (2012) 1.13
Gastric cancer risk in a Mexican population: role of Helicobacter pylori CagA positive infection and polymorphisms in interleukin-1 and -10 genes. Int J Cancer (2006) 1.12
Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology (2012) 1.12
Effect of Helicobacter pylori infection on growth velocity of school-age Andean children. Epidemiology (2011) 1.11
Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America. Cancer Causes Control (2012) 1.11
Pathogenic bacterium Helicobacter pylori alters the expression profile of p53 protein isoforms and p53 response to cellular stresses. Proc Natl Acad Sci U S A (2012) 1.11
Prevalence and frequency of circulating t(14;18)-MBR translocation carrying cells in healthy individuals. Int J Cancer (2009) 1.10
High levels of Epstein-Barr virus DNA in latently infected gastric adenocarcinoma. Lab Invest (2008) 1.10
β-Catenin and p120 mediate PPARδ-dependent proliferation induced by Helicobacter pylori in human and rodent epithelia. Gastroenterology (2011) 1.08
In vitro and in vivo complementation of the Helicobacter pylori arginase mutant using an intergenic chromosomal site. Helicobacter (2006) 1.07
CD14-159C/T and TLR9-1237T/C polymorphisms are not associated with gastric cancer risk in Caucasian populations. Eur J Cancer Prev (2009) 1.07
Positive association of renal insufficiency with agriculture employment and unregulated alcohol consumption in Nicaragua. Ren Fail (2010) 1.07
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities. JAMA (2013) 1.07
Real-time in vivo green fluorescent protein imaging of a murine leishmaniasis model as a new tool for Leishmania vaccine and drug discovery. Clin Vaccine Immunol (2008) 1.07
L-arginine deprivation regulates cyclin D3 mRNA stability in human T cells by controlling HuR expression. J Immunol (2010) 1.06
Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions. Colloids Surf B Biointerfaces (2008) 1.06
Stability and reproducibility of simultaneously detected plasma and serum cytokine levels in asymptomatic subjects. Biomarkers (2010) 1.04
Association of interleukin-1beta gene polymorphisms with precancerous gastric lesions in African Americans and Caucasians. Am J Gastroenterol (2006) 1.04
Cannabinoid neuroimmune modulation of SIV disease. J Neuroimmune Pharmacol (2011) 1.04
Phenotypic differences between esophageal and gastric intestinal metaplasia. Mod Pathol (2004) 1.04
Incidence of esophageal and gastric carcinomas among American Asians/Pacific Islanders, whites, and blacks: subsite and histology differences. Cancer (2006) 1.03
Effects of a new Helicobacter pylori infection on height and weight in Colombian children. Ann Epidemiol (2005) 1.03
Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut (2011) 1.02
Intestinal parasites in Kaposi sarcoma patients in Uganda: indication of shared risk factors or etiologic association. Am J Trop Med Hyg (2008) 1.02
International crises and global health electives: lessons for faculty and institutions. Acad Med (2010) 1.02